Dr. Marson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
400 Parnassus Ave
San Francisco, CA 94143Phone+1 415-353-2326- Is this information wrong?
Education & Training
- Brigham and Women's HospitalResidency, Internal Medicine, 2010 - 2013
- Harvard Medical SchoolClass of 2010
Certifications & Licensure
- CA State Medical License 2012 - 2022
- MA State Medical License 2010 - 2012
Publications & Presentations
PubMed
- 4 citationsModular pooled discovery of synthetic knockin sequences to program durable cell therapies.Franziska Blaeschke, Yan Yi Chen, Ryan Apathy, Bence Daniel, Andy Y Chen, Peixin Amy Chen, Katalin Sandor, Wenxi Zhang, Zhongmei Li, Cody T Mowery, Tori N Yamamoto, Wi...> ;Cell. 2023 Sep 14
- 7 citationsCRISPR screens decode cancer cell pathways that trigger γδ T cell detection.Murad R Mamedov, Shane Vedova, Jacob W Freimer, Avinash Das Sahu, Amrita Ramesh, Maya M Arce, Angelo D Meringa, Mineto Ota, Peixin Amy Chen, Kristina Hanspers, Vinh Q ...> ;Nature. 2023 Sep 1
- 21 citationsPeptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytes.Dana V Foss, Joseph J Muldoon, David N Nguyen, Daniel Carr, Srishti U Sahu, John M Hunsinger, Stacia K Wyman, Netravathi Krishnappa, Rima Mendonsa, Elaine V Schanzer, ...> ;Nature Biomedical Engineering. 2023 May 1
- Join now to see all
Journal Articles
- Reprogramming Human T Cell Function and Specificity with Non-Viral Genome TargetingNeil Romberg, Antoni Ribas, Michael R Lee, Ruby Yu, Gary M Kupfer, Julia Carnevale, Jonathan H Esensten, P Jonathan Li, Han Li, Kevan C Herold, Alexander Marson, Nature
- Author Correction: Discovery of Stimulation-Responsive Immune Enhancers with CRISPR ActivationAlexander Marson, Ansuman T Satpathy, Howard Y Chang, Nature
- CRISPR/Cas9-mediated PD-1 Disruption Enhances Anti-Tumor Efficacy of Human Chimeric Antigen Receptor T CellsAlexander Marson, MD, Nature
Press Mentions
- The Race to Supercharge Cancer-Fighting T CellsJanuary 25th, 2023
- Fred Hutch Hosts Inaugural Dr. E. Donnall Thomas SymposiumOctober 7th, 2022
- Multiple Myeloma Awareness Month: 2022 Immunotherapy Research UpdatesMarch 2nd, 2022
- Join now to see all
Hospital Affiliations
- UCSF Medical CenterSan Francisco, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: